ArticleAnimal bioscience2025
Optimal dietary vitamin B1 content enhanced egg production, eggshell thickness, and serum antioxidant status in breeder geese.
Article in Animal bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveThis study aimed to evaluate the effects of vitamin B1 (VB1) supplementation on laying performance, egg quality, serum biochemical parameters, antioxidant status, and nutrient digestion in breeder geese.
methodsA total of 150 geese (30 males and 120 females, aged 34 weeks) were randomly assigned to 6 dietary treatment groups, each 5 replicates of 5 birds (1 male and 4 females). The geese were fed a basal diet supplemented with 0 (control), 1, 2, 3, 4, or 5 mg/kg of VB1 for 10 weeks.
resultsVB1 supplementation had no significant effects on average feed intake, average egg weight, feed-to-egg ratio, egg shape index, eggshell strength, protein height, and Haugh unit (p>0.05). However, it increased egg-laying rate, eggshell thickness, and yolk color (p<0.05) in a quadratic manner, with the maximum values observed at 2 mg/kg VB1. Supplementing 2 mg/kg VB1 reduced serum aspartate transaminase activity (p<0.05), but did not affect serum alanine transaminase activity, lipid and protein concentrations (p>0.05). Serum glutathione peroxidase and total superoxide dismutase activities were enhanced by VB1 supplementation (p<0.05), while total antioxidant capacity and malondialdehyde concentration remained unchanged (p>0.05). Additionally, VB1 supplementation at 2 mg/ kg increased crude ash digestibility, but did not affect the digestibility of ether extract, crude protein, calcium, and phosphorus.
conclusionDietary supplementing VB1 improved egg-laying performance, egg quality, antioxidant status, and mineral absorption in breeder geese. The optimal dietary VB1 concentration ranged from 3.83 to 4.81 mg/kg for improving egg production and quality, while higher concentrations of 4.99 to 6.51 mg/kg were needed to boost serum antioxidant status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.